Numab to receive R&D funding f or the p reclinical development of ND081 Kaken Pharmaceutical receives an option to in-license ND081 in certain Asian territories in exchange for funding global development up to clinical POC HORGEN, ...
Read MoreDEBx Medical is poised for accelerated growth in chronic wound solutions, bolstered by the second round of investment by TVM Capital Healthcare. AMSTERDAM and DUBAI, United Arab Emirates, Nov. 13, 2024 (GLOBE NEWSWIRE) -- DEBx Medical, an ...
Read MoreATHENS, Greece, Nov. 13, 2024 (GLOBE NEWSWIRE) -- The European Academy of Allergy and Clinical Immunology (EAACI) is proud to announce the inaugural World Anaphylaxis Awareness Day on 21 November 2024 . This landmark initiative, held on ...
Read MoreDECATUR, Ga., Nov. 12, 2024 (GLOBE NEWSWIRE) -- The Mectizan Donation Program applauds Timor-Leste for eliminating lymphatic filariasis (LF) as a public health problem, a remarkable achievement that was recently validated by the World Health ...
Read More·More than 530 million people worldwide living with diabetes are at risk for developing diabetic retinal disease (DRD), the leading cause of blindness in working-age adults. 1 ·DRD is a growing epidemic that is expected to increase as the ...
Read MoreFinding the right therapist can be a big decision. Whether you’re dealing with stress, navigating life changes, or seeking deeper self-understanding, having a supportive, qualified therapist can make all the difference. But how do you go about ...
Read MorePR Newswire TAIPEI, Nov. 15, 2024 TAIPEI, Nov. 15, 2024 /PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") today announces the second positive safety review by the independent Data and Safety Monitoring Board for its Casppian ...
Read MorePR Newswire PHILADELPHIA, Nov. 15, 2024 PHILADELPHIA, Nov. 15, 2024 /PRNewswire/ -- Immunovia (NASDAQ Stockholm: IMMNOV), the pancreatic cancer diagnostics company, will present results from the recently completed model-development study of ...
Read MorePR Newswire KYOTO, Japan, Nov. 15, 2024 Young Scientists Shine at 5th Annual NOSTER & Science Microbiome Prize Ceremony KYOTO, Japan, Nov. 15, 2024 /PRNewswire/ -- Noster Inc. proudly hosted the 5th NOSTER & Science Microbiome Prize ...
Read MorePR Newswire XI'AN, China, Nov. 15, 2024 The National Comprehensive Cancer Network (NCCN) is honored to participate in the 4th International Congress of the Asian Oncology Society and the Chinese Congress on Holistic Integrative Oncology ...
Read MorePR Newswire VICTORIA, BC, Nov. 14, 2024 VICTORIA, BC, Nov. 14, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary ...
Read MoreCanada NewsWire SHERBROOKE, QC, Nov. 14, 2024 Canada-Quebec Agreement on Addictions and Substance Use SHERBROOKE, QC, Nov. 14, 2024 /CNW/ - Toxic illegal drugs and overdoses are causing increasing harm across Canada, including here in ...
Read MorePR Newswire WOBURN, Mass., Nov. 14, 2024 WOBURN, Mass., Nov. 14, 2024 /PRNewswire/ -- Azurity Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has approved Danziten™, the first and only nilotinib with no ...
Read MorePR Newswire TOKYO and CAMBRIDGE, Mass., Nov. 14, 2024 TOKYO and CAMBRIDGE, Mass., Nov. 14, 2024 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...
Read MorePR Newswire NEW YORK, Nov. 13, 2024 NEW YORK, Nov. 13, 2024 /PRNewswire/ -- Fourth Frontier, a medical technology company based out of New York and Bangalore, announced the 510(k) clearance of the Frontier X Plus from the U.S. FDA. The ...
Read MorePR Newswire VIENNA, Nov. 13, 2024 VIENNA, Nov. 13, 2024 /PRNewswire/ -- ImageBiopsy Lab, a leading provider of AI-powered musculoskeletal imaging solutions, has launched IB Lab FROG. This AI module, CE-cleared under the European Medical ...
Read MorePR Newswire MIAMI, Nov. 13, 2024 Millions of people across the United States navigate the challenges of diabetes, a complex condition that requires ongoing management. Viewpoint with Dennis Quaid sheds light on this journey, featuring HME ...
Read MorePR Newswire MUSCATINE, Iowa, Nov. 13, 2024 World's Best Cat Litter® Introduces First Veterinary Approved Blood Detecting Litter Box Monitoring Solution: Health Check-In™ Boosters™ Litter Additive MUSCATINE, Iowa , Nov. 13, 2024 ...
Read MorePR Newswire MINNEAPOLIS, Nov. 13, 2024 Pet Toxicology Experts Slice Up a List of Common Yuletide Toxins MINNEAPOLIS, Nov. 13, 2024 /PRNewswire/ -- The perfect holiday season is filled with food, fun, family and friends. For your pets, ...
Read MorePR Newswire VICTORIA, BC, Nov. 12, 2024 VICTORIA, BC, Nov. 12, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company developing precision drug ...
Read MorePR Newswire LAS VEGAS, Nov. 12, 2024 After over a decade without notable progress in treating chronic obstructive pulmonary disease, patients with this ongoing condition now have two new treatment options, with more expected in the future. ...
Read MorePR Newswire NEW YORK, Nov. 12, 2024 NEW YORK, Nov. 12, 2024 /PRNewswire/ -- Report with the AI impact on market trends - The global wound care market size is estimated to grow by USD 6.95 billion from 2024-2028, according to Technavio. The ...
Read MoreCanada NewsWire SHEET HARBOUR, NS, Nov. 12, 2024 SHEET HARBOUR, NS, Nov. 12, 2024 /CNW/ - Canada is facing a shortage of health professionals, particularly in rural and remote communities that face unique challenges attracting and retaining ...
Read MoreCanada NewsWire TORONTO, Nov. 12, 2024 TORONTO, Nov. 12, 2024 /CNW/ - Get Gambit, a leading provider of healthcare solutions for men across Canada, is transforming the way men address critical health concerns. By offering discreet, ...
Read MorePR Newswire SAN DIEGO, Nov. 12, 2024 Results to be Featured in Oral Late Breaker Presentation SAN DIEGO, Nov. 12, 2024 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company ...
Read MorePR Newswire CHANHASSEN, Minn., Nov. 12, 2024 Open to anyone via the Life Time App at Noon CT CHANHASSEN, Minn., Nov. 12, 2024 /PRNewswire/ -- Life Time (NYSE: LTH), which continues to innovate in the performance and longevity space ...
Read MorePR Newswire HOUSTON, Nov. 12, 2024 Pre-conference Course and General Session Registration Announcement for the American Society for Preventive Cardiology HOUSTON, Nov. 12, 2024 /PRNewswire/ -- The American Society for Preventive ...
Read MorePR Newswire CHICAGO, Nov. 12, 2024 CHICAGO, Nov. 12, 2024 /PRNewswire/ -- My Green Mattress announces the biggest discounts of the year for their Black Friday Sale. Customers can enjoy exclusive pricing on premium, eco-friendly mattresses ...
Read MorePR Newswire MIAMI, Nov. 12, 2024 The App Expands its Commitment to Fight Text Neck with its Latest Innovation MIAMI, Nov. 12, 2024 /PRNewswire/ -- In today's digital age, posture-related issues like "Text Neck" and "Forward Head Posture" ...
Read MorePR Newswire BETHESDA, Md., Nov. 12, 2024 Findings could point to new ways to treat RAS-driven cancers BETHESDA, Md., Nov. 12, 2024 /PRNewswire/ -- Researchers at the National Institutes of Health (NIH) and their collaborators have ...
Read MoreCanada NewsWire MISSISSAUGA, ON, Nov. 12, 2024 MISSISSAUGA, ON, Nov. 12, 2024 /CNW/ - GSK announced today that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or disease-related symptoms, in adult ...
Read MorePR Newswire WASHINGTON, Nov. 12, 2024 Detection of Alzheimer's disease in its early stages is crucial to initiating treatment WASHINGTON, Nov. 12, 2024 /PRNewswire/ -- The availability of amyloid-reducing therapies now makes detection of ...
Read MorePR Newswire BEIJING, Nov. 12, 2024 BEIJING, Nov. 12, 2024 /PRNewswire/ -- Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087) announced the positive topline results of a Phase 1 clinical trial its oral glucagon-like ...
Read MorePR Newswire GENEVA and LILONGWE, Malawi, Nov. 12, 2024 GENEVA and LILONGWE, Malawi, Nov. 12, 2024 /PRNewswire/ -- Today marks the launch of a transformative initiative as Access Accelerated and the World Bank come together in a new technical ...
Read MorePR Newswire REYKJAVIK, Iceland, Nov. 12, 2024 REYKJAVIK, Iceland, Nov. 12, 2024 /PRNewswire/ -- New study from deCODE genetics/Amgen highlights the importance of BMI in pathogenesis of disease, suggesting that reducing BMI alone could lower ...
Read MorePR Newswire DUSSELDORF, Germany, Nov. 12, 2024 DUSSELDORF, Germany, Nov. 12, 2024 /PRNewswire/ -- Edan Instruments Inc. (300206.SZ), a leading global provider of medical and healthcare solutions, showcased its latest product innovations at ...
Read MoreSubscribe to our Free Newsletters!